logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (viii) All inpatient clients, primary drug distribution by age (%)

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Opioids4.923.137.252.658.458.455.242.11780312
Cocaine1.22.44.86.57.38.48.75.523321
Stimulants12.318.117.313.110.29.29.310.7468912
Hypnotics and sedatives1.21.63.02.93.75.07.221.319652
Hallucinogens0.00.40.80.50.60.30.20.11810
Volatile substances32.17.21.00.60.50.50.30.34112
Cannabis 39.537.925.314.810.69.38.27.258560
Other substances 8.69.310.68.98.98.911.012.736081
Total8125987436874971254427292735023684530
 

Notes:

The countries supplying data are:

AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.

Last data available from Poland refers to 2009.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Monday, 09 July 2012